Roche
RO.SW
#33
Rank
A$587.90 B
Marketcap
A$737.86
Share price
-0.64%
Change (1 day)
22.75%
Change (1 year)

EPS for Roche (RO.SW)

EPS in 2025: A$30.69

According to Roche's latest financial reports the company's current EPS (TTM) is A$30.69. In 2025 the company made an earnings per share (EPS) of A$30.69 an increase over its 2024 EPS that were of A$17.28.

EPS history for Roche from 1998 to 2025

Annual EPS

Year EPS Change
2025A$30.6977.67%
2024A$17.28-32.84%
2023A$25.721.95%
2022A$25.23-6.29%
2021A$26.92-5.53%
2020A$28.5016.56%
2019A$24.4530.3%
2018A$18.7720.22%
2017A$15.61-5.81%
2016A$16.574.62%
2015A$15.84-5.13%
2014A$16.70-25.05%
2013A$22.2821.73%
2012A$18.303.82%
2011A$17.638.16%
2010A$16.3023.72%
2009A$13.17-12.31%
2008A$15.02-0.34%
2007A$15.0732.13%
2006A$11.4142.56%
2005A$8.00-22.7%
2004A$10.35132.85%
2003A$4.45-150.87%
2002A-$8.74-209.09%
2001A$8.01-57.03%
2000A$18.6453.29%
1999A$12.1631.24%
1998A$9.27

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$10.03-67.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$7.88-74.31%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$1.07-96.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$4.06-86.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$26.10-14.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$2.97-90.31%๐Ÿ‡ซ๐Ÿ‡ท France
Becton Dickinson
BDX
A$5.41-82.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$1.49-95.14%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$4.32-85.92%๐Ÿ‡ฌ๐Ÿ‡ง UK